Huge Business Opportunities in the Life Science Sector will boost growth of Mycoplasma Testing Marke by Dhanashree

Huge Business Opportunities in the Life Science Sector will boost growth of Mycoplasma Testing Market Till 2025

â&#x20AC;&#x153;The global mycoplasma testing market size was valued at USD 446.9 million in 2016. With growing R&D investments in the field of life sciences, the demand for mycoplasma testing products are anticipated to rise in the near future.â&#x20AC;?

The global mycoplasma testing market is expected to reach a value of USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. With growing R&D investments in the field of life sciences, the demand for mycoplasma testing products are anticipated to rise in the near future. Huge opportunities in the life sciences segment are spurring the market growth. Hence, a large amount of investment is being made in the biotechnology and pharmaceutical industries with rising level of healthcare spending across the globe. This is expected to trigger high growth of mycoplasma testing market. Access Full Research Report on Global Mycoplasma Testing Market: http://www.grandviewresearch.com/industry-analysis/mycoplasma-testingmarket Investment in R&D activities by pharmaceutical and biotechnology companies is increasingly being supported by the government. Researches involving drug discovery and development, receive funding from the governmental bodies to a great extent.

Moreover, governmental initiatives in the form of awareness campaigns for chronic diseases such as cancer are also encouraging research-based activities. Thus, the aforementioned factors are expected to drive the market growth. Mycoplasma contamination of cell culture is a growing concern for most of the research scientists for decades. Mycoplasma infection arises majorly from laboratory workers as human mycoplasma contamination occurs at a faster rate. In order to combat further contamination, mycoplasma tests are being conducted, which is expected to increase the demand of the related products. Further key findings from the study suggest: 

In 2016, kits & reagents dominated the market and is also expected to show highest CAGR over the forecast period owing to its wider application in mycoplasma tests



Amongst the technology segment, Polymerase Chain Reaction (PCR) held the largest share in 2016 owing to the delivery of fast & accurate results associated with this technology



Cell line testing is anticipated to exhibit highest CAGR over the forecast period due to the increasing risk of cell line contamination



In 2016, pharmaceutical and biotechnology companies accounted for the largest market share due to rising number of research activities in drug discovery and development



North America dominated the market in 2016 owing to rising healthcare spending levels and government funding for life science-related research



Some of the key players are Merck KGaA; Sigma-Aldrich Co.; Thermo Fisher Scientific; Lonza Group Ltd.; Charles River Laboratories International, Inc.; PromoCell GmbH; and Bionique Testing Laboratories, Inc.

Grand View Research has segmented the Mycoplasma Testing Market on the basis of product, technology, application, end-use, and region: Read Our Blogs on Reports from this category By Grand View Research: http://www.grandviewresearch.com/blogs/healthcare

Table of Content of Global Mycoplasma Testing Market Research Report: Chapter 1 Research Methodology 1.1 Country Wise Market: Base Estimates 1.2 Global Market: CAGR Calculation 1.3 Region Based Segment Share Calculation 1.4 Research Scope & Assumptions 1.5 List of Data Sources 1.5.1 Data for primary interviews, by sources 1.5.2 Data for primary interviews, by region Chapter 2 Executive Summary 2.1 Market Snapshot Chapter 3 Mycoplasma Testing Market Variables, Trends & Scope 3.1 Market Segmentation & Scope 3.2 Market Driver Analysis 3.2.1 Increasing R&D investments in life sciences 3.2.2 Rising government support towards pharmaceutical and biotechnology industries 3.2.3 Rising cell culture contamination 3.3 Market Restraint Analysis 3.3.1 High cost of research in cell biology 3.4 Key Opportunities Prioritized 3.4.1 Key opportunities prioritized, by product 3.4.2 Key opportunities prioritized, by technology 3.4.3 Key opportunities prioritized, by application 3.4.4 Key opportunities prioritized, by end-use 3.5 Mycoplasma Testing - SWOT Analysis, By Factor (Political & Legal,

Economic And Technological) 3.6 Industry Analysis - Porterâ&#x20AC;&#x2122;s 3.7 Competitive Landscape: Market Position Analysis, 2016 Chapter 4 Mycoplasma Testing: Product Estimates & Trend Analysis 4.1 Mycoplasma Testing Market: Product Movement Analysis 4.2 Instruments 4.2.1 Instruments market estimate & forecast, 2014 - 2025 (USD Million) 4.3 Kits & Reagents 4.3.1 Kits & reagents market estimate & forecast, 2014 - 2025 (USD Million) 4.3.2 PCR Assays 4.3.2.1 PCR assays market estimate & forecast, 2014 - 2025 (USD Million) 4.3.3 Nucleic Acid Detection Kits 4.3.3.1 Nucleic acid detection kits market estimate & forecast, 2014 2025 (USD Million) 4.3.4 Stains 4.3.4.1 Stains market estimate & forecast, 2014 - 2025 (USD Million) 4.3.5 Standards & Controls 4.3.5.1 Standards & controls market estimate & forecast, 2014 - 2025 (USD Million) 4.3.6 Others 4.3.6.1 Others market estimate & forecast, 2014 - 2025 (USD Million) 4.4 Services 4.4.1 Services market estimate & forecast, 2014 - 2025 (USD Million) Chapter 5 Mycoplasma Testing: Technology Estimates & Trend Analysis 5.1 Mycoplasma Testing market: Technology movement analysis

5.2 PCR 5.2.1 PCR market estimate & forecast, 2014 - 2025 (USD Million) 5.3 ELISA 5.3.1 ELISA market estimate & forecast, 2014 - 2025 (USD Million) 5.4 Direct Assay 5.4.1 Direct assay market estimate & forecast, 2014 - 2025 (USD Million) 5.5 Indirect Assay 5.5.1 Indirect assay market estimate & forecast, 2014 - 2025 (USD Million) 5.6 Microbial Culture Techniques 5.6.1 Microbial culture techniques market estimate & forecast, 2014 - 2025 (USD Million) 5.7 Enzymatic Methods 5.7.1 Enzymatic methods market estimate & forecast, 2014 - 2025 (USD Million) Chapter 6 Mycoplasma Testing: Application Estimates & Trend Analysis 6.1 Mycoplasma Testing Market: Application Movement Analysis 6.2 Cell Line Testing 6.2.1 Cell line testing market estimate & forecast, 2014 - 2025 (USD Million) 6.3 Virus Testing 6.3.1 Virus testing market estimate & forecast, 2014 - 2025 (USD Million) 6.4 End of Production Cells Testing 6.4.1 End of production cells testing market estimate & forecast, 2014 2025 (USD Million) 6.5 Others 6.5.1 Others market estimate & forecast, 2014 - 2025 (USD Million) Chapter 7 Mycoplasma Testing: End-Use Estimates & Trend Analysis

7.1 Mycoplasma Testing Market: End-Use Movement Analysis 7.2 Academic Research Institutes 7.2.1 Academic research institutes market estimate & forecast, 2014 2025 (USD Million) 7.3 Cell Banks 7.3.1 Cell banks market estimate & forecast, 2014 - 2025 (USD Million) 7.4 Contract Research Organizations 7.4.1 Contract research organizations market estimate & forecast, 2014 2025 (USD Million) 7.5 Pharmaceutical & Biotechnology Companies 7.5.1 Pharmaceutical & biotechnology companies market estimate & forecast, 2014 - 2025 (USD Million) 7.6 Others 7.6.1 Others market estimate & forecast, 2014 - 2025 (USD Million) Chapter 8 Mycoplasma Testing Market: Regional Estimates & Trend Analysis, by Product, Technology, Application, End-Use 8.1 Mycoplasma testing market share by region, 2017 & 2025 8.2 North America 8.2.1 U.S. 8.2.1.1 U.S. mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.2.1.2 U.S. mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.2.1.3 U.S. mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.2.1.4 U.S. mycoplasma testing market, by end-use, 2014 - 2025 (USD Million)

8.2.2 Canada 8.2.2.1 Canada mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.2.2.2 Canada mycoplasma testing market, by technology, 2014 2025 (USD Million) 8.2.2.3 Canada mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.2.2.4 Canada mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.3 Europe 8.3.1 Germany 8.3.1.1 Germany mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.3.1.2 Germany mycoplasma testing market, by technology, 2014 2025 (USD Million) 8.3.1.3 Germany mycoplasma testing market, by application, 2014 2025 (USD Million) 8.3.1.4 Germany mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.3.2 UK 8.3.2.1 UK mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.3.2.2 UK mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.3.2.3 UK mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.3.2.4 UK mycoplasma testing market, by end-use, 2014 - 2025 (USD

Million) 8.4 Asia Pacific 8.4.1 Japan 8.4.1.1 Japan mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.4.1.2 Japan mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.4.1.3 Japan mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.4.1.4 Japan mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.4.2 China 8.4.2.1 China mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.4.2.2 China mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.4.2.3 China mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.4.2.4 China mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.4.3 India 8.4.3.1 India mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.4.3.2 India mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.4.3.3 India mycoplasma testing market, by application, 2014 - 2025 (USD Million)

8.4.3.4 India mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.5 Latin America 8.5.1 Brazil 8.5.1.1 Brazil mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.5.1.2 Brazil mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.5.1.3 Brazil mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.5.1.4 Brazil mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.5.2 Mexico 8.5.2.1 Mexico mycoplasma testing market, by product, 2014 - 2025 (USD Million) 8.5.2.2 Mexico mycoplasma testing market, by technology, 2014 - 2025 (USD Million) 8.5.2.3 Mexico mycoplasma testing market, by application, 2014 - 2025 (USD Million) 8.5.2.4 Mexico mycoplasma testing market, by end-use, 2014 - 2025 (USD Million) 8.6 MEA 8.6.1 South Africa 8.6.1.1 South Africa mycoplasma testing market, by product, 2014 2025 (USD Million) 8.6.1.2 South Africa mycoplasma testing market, by technology, 2014 2025 (USD Million)

8.6.1.3 South Africa mycoplasma testing market, by application, 2014 2025 (USD Million) 8.6.1.4 South Africa mycoplasma testing market, by end-use, 2014 2025 (USD Million) Chapter 9 Competitive Landscape 9.1 Company Profiles 9.1.1 Thermo Fisher Scientific, Inc. 9.1.1.1 Company overview 9.1.1.2 Financial performance 9.1.1.3 Product benchmarking 9.1.1.4 Strategic initiatives 9.1.2 Merck KGaA 9.1.2.1 Company overview 9.1.2.2 Financial performance 9.1.2.3 Product benchmarking 9.1.2.4 Strategic initiatives 9.1.3 Lonza Group Ltd. 9.1.3.1 Company overview 9.1.3.2 inancial performance 9.1.3.3 Product benchmarking 9.1.3.4 Strategic initiatives 9.1.4 Promo Cell GmbH 9.1.4.1 Company overview 9.1.4.2 Financial performance 9.1.4.3 Product benchmarking 9.1.4.4 Strategic initiatives 9.1.5 American Type Culture Collection

9.1.5.1 Company overview 9.1.5.2 Financial performance 9.1.5.3 Product benchmarking 9.1.5.4 Strategic initiatives 9.1.6 Charles River Laboratories International, Inc. 9.1.6.1 Company overview 9.1.6.2 Financial performance 9.1.6.3 Product benchmarking 9.1.6.4 Strategic initiatives 9.1.7 Bionique Testing Laboratories, Inc. 9.1.7.1 Company overview 9.1.7.2 Financial performance 9.1.7.3 Product benchmarking 9.1.7.4 Strategic initiatives 9.1.8 Biological Industries Israel Beit Haemek Ltd. 9.1.8.1 Company overview 9.1.8.2 inancial performance 9.1.8.3 Product benchmarking 9.1.8.4 Strategic initiatives 9.1.9 InvivoGen 9.1.9.1 Company overview 9.1.9.2 Financial performance 9.1.9.3 Product benchmarking 9.1.9.4 Strategic initiatives

About Grand View Research, Inc.:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com